Jane Street’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-34,700
Closed -$4.01M 10122
2023
Q3
$4.01M Sell
34,700
-425,300
-92% -$45.7M ﹤0.01% 2933
2023
Q2
$47.3M Buy
460,000
+386,000
+522% +$40.7M 0.02% 619
2023
Q1
$8.08M Sell
74,000
-235,500
-76% -$26M ﹤0.01% 1859
2022
Q4
$35.2M Buy
309,500
+232,300
+301% +$19.3M 0.02% 683
2022
Q3
$4.78M Sell
77,200
-10,700
-12% -$748K ﹤0.01% 2703
2022
Q2
$7.01M Buy
87,900
+9,500
+12% +$900K ﹤0.01% 2178
2022
Q1
$8.25M Sell
78,400
-17,400
-18% -$1.7M ﹤0.01% 2246
2021
Q4
$10.3M Buy
95,800
+33,800
+55% +$3.69M ﹤0.01% 1848
2021
Q3
$6.79M Sell
62,000
-9,100
-13% -$945K ﹤0.01% 2304
2021
Q2
$6.66M Sell
71,100
-280,500
-80% -$25.8M ﹤0.01% 2236
2021
Q1
$32.4M Buy
351,600
+115,700
+49% +$9.76M 0.02% 659
2020
Q4
$17.3M Buy
235,900
+19,900
+9% +$1.48M 0.01% 963
2020
Q3
$16.8M Buy
216,000
+168,500
+355% +$11.6M 0.01% 870
2020
Q2
$2.64M Buy
+47,500
New +$2.03M ﹤0.01% 2677
2018
Q2
Sell
-16,300
Closed -$231K 5962
2018
Q1
$231K Buy
+16,300
New +$241K ﹤0.01% 4307
2017
Q4
Sell
-12,600
Closed -$160K 5478
2017
Q3
$160K Buy
+12,600
New +$160K ﹤0.01% 4186
2017
Q2
Sell
-27,000
Closed -$399K 5151
2017
Q1
$399K Sell
27,000
-111,800
-81% -$1.81M ﹤0.01% 3114
2016
Q4
$2.25M Buy
+138,800
New +$2.52M 0.01% 1212
2016
Q3
Sell
-10,000
Closed -$165K 4790
2016
Q2
$165K Buy
+10,000
New +$162K ﹤0.01% 3807
2015
Q4
Sell
-51,300
Closed -$1.02M 4687
2015
Q3
$1.02M Buy
+51,300
New +$1.62M 0.01% 1622

Other funds holding HZNP

Jane Street's HZNP Position: Q4 2023 in Review

Jane Street sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 13,042 shares — an estimated $1.51M sold.

Jane Street first reported a position in HZNP in Q4 2013 and held it in 30 quarters. The position peaked at $29.2M in Q3 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Jane Street reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Jane Street sold 13,042 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.51M.
  • Jane Street first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 30 quarters.
  • Jane Street's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $29.2M in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.